ISONIAZID\PYRAZINAMIDE\RIFAMPIN: 412 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
412
Total FAERS Reports
35 (8.5%)
Deaths Reported
253
Hospitalizations
412
As Primary/Secondary Suspect
27
Life-Threatening
12
Disabilities
First Report: 200502 · Latest Report: 20250915
What Are the Most Common ISONIAZID\PYRAZINAMIDE\RIFAMPIN Side Effects?
#1 Most Reported
Hepatic cytolysis
50 reports (12.1%)
#2 Most Reported
Drug reaction with eosinophilia and systemic symptoms
39 reports (9.5%)
#3 Most Reported
Hepatocellular injury
37 reports (9.0%)
All ISONIAZID\PYRAZINAMIDE\RIFAMPIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic cytolysis | 50 | 12.1% | 5 | 31 |
| Drug reaction with eosinophilia and systemic symptoms | 39 | 9.5% | 9 | 27 |
| Hepatocellular injury | 37 | 9.0% | 4 | 24 |
| Cholestasis | 32 | 7.8% | 10 | 16 |
| Thrombocytopenia | 20 | 4.9% | 3 | 18 |
| Rash maculo-papular | 19 | 4.6% | 2 | 14 |
| Rash | 17 | 4.1% | 9 | 7 |
| Pyrexia | 16 | 3.9% | 2 | 12 |
| Jaundice | 15 | 3.6% | 2 | 14 |
| Pruritus | 15 | 3.6% | 0 | 14 |
| Mixed liver injury | 14 | 3.4% | 1 | 14 |
| Vomiting | 13 | 3.2% | 1 | 11 |
| Condition aggravated | 12 | 2.9% | 0 | 7 |
| Eosinophilia | 12 | 2.9% | 2 | 9 |
| Hepatic failure | 12 | 2.9% | 4 | 11 |
| Nausea | 12 | 2.9% | 0 | 9 |
| Acute hepatic failure | 11 | 2.7% | 2 | 4 |
| Hepatitis | 11 | 2.7% | 0 | 10 |
| Hepatotoxicity | 11 | 2.7% | 0 | 4 |
| Neutropenia | 11 | 2.7% | 0 | 8 |
Who Reports ISONIAZID\PYRAZINAMIDE\RIFAMPIN Side Effects? Age & Gender Data
Gender: 40.2% female, 59.8% male. Average age: 50.8 years. Most reports from: FR. View detailed demographics →
Is ISONIAZID\PYRAZINAMIDE\RIFAMPIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 5 | 2 | 5 |
| 2009 | 1 | 0 | 0 |
| 2010 | 3 | 0 | 3 |
| 2011 | 1 | 0 | 0 |
| 2012 | 5 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 35 | 0 | 27 |
| 2015 | 32 | 5 | 19 |
| 2016 | 23 | 2 | 18 |
| 2017 | 23 | 0 | 19 |
| 2018 | 24 | 0 | 10 |
| 2019 | 41 | 12 | 24 |
| 2020 | 33 | 1 | 26 |
| 2021 | 22 | 3 | 12 |
| 2022 | 21 | 0 | 13 |
| 2023 | 36 | 3 | 17 |
| 2024 | 38 | 6 | 22 |
| 2025 | 19 | 0 | 15 |
What Is ISONIAZID\PYRAZINAMIDE\RIFAMPIN Used For?
| Indication | Reports |
|---|---|
| Tuberculosis | 196 |
| Pulmonary tuberculosis | 78 |
| Lymph node tuberculosis | 26 |
| Disseminated tuberculosis | 20 |
| Product used for unknown indication | 13 |
| Bone tuberculosis | 10 |
| Meningitis tuberculous | 7 |
| Peritoneal tuberculosis | 7 |
| Pulmonary tuberculoma | 5 |
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs Alternatives: Which Is Safer?
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISONIAZID\PYRIDOXINE\SULFAMETHOXAZOLE\TRIMETHOPRIM
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISONIAZID\RIFAMPIN
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOPROPANOLAMINE
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOPROPYL ALCOHOL
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOPROPYL ALCOHOL\LEUPROLIDE
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOPROPYL ALCOHOL\LEUPROLIDE\NORETHINDRONE
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOPROTERENOL
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOSORBIDE
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOSORBIDE DINITRATE
ISONIAZID\PYRAZINAMIDE\RIFAMPIN vs ISOSORBIDE MONONITRATE
Official FDA Label for ISONIAZID\PYRAZINAMIDE\RIFAMPIN
Official prescribing information from the FDA-approved drug label.